Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 4/2016

21.04.2016 | ORIGINAL ARTICLE

Total meso-pancreatoduodenum excision with pancreaticoduodenectomy in lower biliary tract cancer

verfasst von: Yasunari Kawabata, Hikota Hayashi, Noriyoshi Ishikawa, Yoshitsugu Tajima

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Incomplete tumor resection with insufficient lymphadenectomy following a pancreaticoduodenectomy (PD) for lower biliary tract cancer results in a dismal outcome. This study aimed to compare the short-term outcomes of PD between total meso-pancreatoduodenum excision (tMPDe) and the conventional procedure for lower biliary tract cancer.

Methods

Patients who underwent PD for lower biliary tract cancer between May 2003 and March 2015 were included in this study. We have devised a new surgical technique, tMPDe, as a mesenteric plane surgery with an artery-first approach, for achieving complete clearance of the peripancreatic retroperitoneal tissue and lymph nodes. Perioperative data, including complications and short-term survival, were evaluated.

Results

A total of 74 consecutive patients underwent a PD: 41 patients underwent conventional PD (cPD), and 33 underwent tMPDe. The tumor stages were similar in the two study groups. R0 was achieved in 32 patients (78.0 %) with cPD and in 31 patients (93.9 %) with tMPDe (p = 0.046). The survival rates at 1 and 3 years after surgery were 82.5 and 64.0 % for the cPD group, with a median follow-up period of 44.6 months, and 92.8 and 84.4 % for the tMPDe group, with a median follow-up period of 28.6 months, respectively.

Conclusions

The tMPDe technique significantly increased R0 resection and contributed to better oncological outcomes in lower biliary tract cancer.
Literatur
1.
Zurück zum Zitat Michelassi F, Erroi F, Dawson PJ et al (1989) Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg 210:544–554CrossRefPubMedPubMedCentral Michelassi F, Erroi F, Dawson PJ et al (1989) Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg 210:544–554CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Michalski CW, Weitz J, Büchler MW (2007) Surgery insight: surgical management of pancreatic cancer. Nat Clin Pract Oncol 4:526–535CrossRefPubMed Michalski CW, Weitz J, Büchler MW (2007) Surgery insight: surgical management of pancreatic cancer. Nat Clin Pract Oncol 4:526–535CrossRefPubMed
4.
Zurück zum Zitat Esposite I, Kleeff J, Bergmann F et al (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660CrossRef Esposite I, Kleeff J, Bergmann F et al (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660CrossRef
5.
Zurück zum Zitat Gockel I, Domeyer M, Wolloscheck T et al (2007) Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol 5:44CrossRefPubMedPubMedCentral Gockel I, Domeyer M, Wolloscheck T et al (2007) Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol 5:44CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Gaedcke J, Gunawan B, Grade M et al (2010) The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbacks Arch Surg 395:451–458CrossRef Gaedcke J, Gunawan B, Grade M et al (2010) The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbacks Arch Surg 395:451–458CrossRef
7.
Zurück zum Zitat Jamieson NB, Foulis AK, Oien KA et al (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251:1003–1010CrossRefPubMed Jamieson NB, Foulis AK, Oien KA et al (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251:1003–1010CrossRefPubMed
8.
Zurück zum Zitat Menon KV, Gomez D, Smith AM et al (2009) Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathological Protocol (LEEPP). HBP 11:18–24 Menon KV, Gomez D, Smith AM et al (2009) Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathological Protocol (LEEPP). HBP 11:18–24
9.
Zurück zum Zitat Noto M, Miwa K, Kitagawa H et al (2005) Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery. Am J Surg Pathol 29:1056–1061PubMed Noto M, Miwa K, Kitagawa H et al (2005) Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery. Am J Surg Pathol 29:1056–1061PubMed
10.
Zurück zum Zitat Kayahara M, Nagakawa, Ueno K et al (1995) Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion. Surgery 117:616–623CrossRefPubMed Kayahara M, Nagakawa, Ueno K et al (1995) Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion. Surgery 117:616–623CrossRefPubMed
11.
Zurück zum Zitat Popescu I, Dumitrascu T (2011) Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma. Hepatogastroenterology 58:202–207PubMed Popescu I, Dumitrascu T (2011) Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma. Hepatogastroenterology 58:202–207PubMed
12.
Zurück zum Zitat Kawabata Y, Tanaka T, Nishi T et al (2012) Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol 38:574–579CrossRefPubMed Kawabata Y, Tanaka T, Nishi T et al (2012) Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol 38:574–579CrossRefPubMed
13.
Zurück zum Zitat Horiguchi A, Ishihara S, Ito M et al (2002) Three-dimensional models of arteries constructed using multidetector-row CT images to perform pancreatoduodenectomy safely following dissection of the inferior pancreaticoduodenal artery. J Hepatobiliary Pancreat Sci 17:523–526CrossRef Horiguchi A, Ishihara S, Ito M et al (2002) Three-dimensional models of arteries constructed using multidetector-row CT images to perform pancreatoduodenectomy safely following dissection of the inferior pancreaticoduodenal artery. J Hepatobiliary Pancreat Sci 17:523–526CrossRef
14.
Zurück zum Zitat Japanese Society of Biliary Surgery. Classification of biliary tract carcinoma (2004) 2nd English edition. Tokyo, Kanehara Japanese Society of Biliary Surgery. Classification of biliary tract carcinoma (2004) 2nd English edition. Tokyo, Kanehara
15.
Zurück zum Zitat Sobin LH, Wittekind C (Eds) (2010) TNM classification of malignant tumors, 7th ed. UICC International Union Against Cancer. New York, Wiley-Liss Sobin LH, Wittekind C (Eds) (2010) TNM classification of malignant tumors, 7th ed. UICC International Union Against Cancer. New York, Wiley-Liss
16.
Zurück zum Zitat Nimura Y, Nagino M, Takao S et al (2012) Standard versus extended lymphadenectomy in radical pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19:230–241CrossRefPubMed Nimura Y, Nagino M, Takao S et al (2012) Standard versus extended lymphadenectomy in radical pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19:230–241CrossRefPubMed
17.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13CrossRefPubMed Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13CrossRefPubMed
18.
Zurück zum Zitat Agrawal MK, Thakur DS, Somashekar U et al (2010) Mesopancreas: myth or reality? JOP 11:230–233PubMed Agrawal MK, Thakur DS, Somashekar U et al (2010) Mesopancreas: myth or reality? JOP 11:230–233PubMed
19.
Zurück zum Zitat Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482CrossRefPubMed Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482CrossRefPubMed
20.
Zurück zum Zitat Pessaux P, Varma D, Arnaud JP (2006) Pancreaticoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg 10:607–611CrossRefPubMed Pessaux P, Varma D, Arnaud JP (2006) Pancreaticoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg 10:607–611CrossRefPubMed
21.
Zurück zum Zitat Weitz J, Rahabari N, Koch M et al (2010) The “artery first” approach for resection of pancreatic head cancer. J Am Coll 210:e1–e4CrossRef Weitz J, Rahabari N, Koch M et al (2010) The “artery first” approach for resection of pancreatic head cancer. J Am Coll 210:e1–e4CrossRef
22.
Zurück zum Zitat Inoue Y, Saiura A, Yoshioka R et al (2015) Pancreatoduodenectomy with systematic mesopancreas dissection using a supracolic anterior artery-first approach. Ann Surg 262:1092–101CrossRefPubMed Inoue Y, Saiura A, Yoshioka R et al (2015) Pancreatoduodenectomy with systematic mesopancreas dissection using a supracolic anterior artery-first approach. Ann Surg 262:1092–101CrossRefPubMed
Metadaten
Titel
Total meso-pancreatoduodenum excision with pancreaticoduodenectomy in lower biliary tract cancer
verfasst von
Yasunari Kawabata
Hikota Hayashi
Noriyoshi Ishikawa
Yoshitsugu Tajima
Publikationsdatum
21.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 4/2016
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-016-1435-y

Weitere Artikel der Ausgabe 4/2016

Langenbeck's Archives of Surgery 4/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.